arrow
J

Joaquín Osca

hospital universitario y politecnico la fe
H指数:26
被引数:2,950

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Pulsed Field Ablation as First-Line Therapy for the Treatment of Atrial Fibrillation: a FARADISE Sub-Analysis

脉冲场消融作为心房颤动治疗的一线疗法:一项FARADISE亚组分析

2026-10-140
OAAI
Adjunctive posterior wall ablation with a balloon-in-basket pulsed-field ablation catheter in atrial fibrillation: feasibility, safety, and insights into targeted lesion delivery from the VOLT CE Mark study

附加后壁消融技术在心房颤动中的应用:使用球囊-篮状脉冲场消融导管进行消融的可行性、安全性及对靶向消融位点传递的见解——来自VOLT CE认证研究

2026-05-010
PRE
Safety and Effectiveness of the TactiFlex Duo System: 6-Month Results of the FOCALFLEX Study

TactiFlex Duo系统安全性与有效性:FOCALFLEX研究6个月结果

2026-05-010
OA
Balloon-in-Basket Pulsed Field Ablation for Pulmonary Vein Isolation

篮内球囊脉冲场消融治疗肺静脉隔离

2026-02-050
OAAI
Real-world experience with the pentaspline pulsed field ablation system: one-year outcomes of the FARADISE registry

真实世界中使用五尖波脉冲场消融系统的经验:FARADISE注册研究的一年结果

2025-09-010
OAAI
Sex-specific response to cardiac resynchronization therapy: the BIO|WOMEN trial

性别特异性对心脏再同步化治疗的反应:BIO|WOMEN 试验

2025-06-190
PRE
Safety and effectiveness of a novel balloon-in-basket pulsed-field ablation catheter for the treatment of paroxysmal and persistent AF: Volt-AF IDE trial acute results

新型球囊-篮状脉冲场消融导管治疗阵发性和持续性AF的安全性与有效性:Volt-AF IDE试验急性结果

2025-04-260
OAAI
High-Power Short-Duration Radiofrequency Application for Faster and Safer Pulmonary Vein Isolation The POWER-FAST III Trial

高功率短持续时间射频应用于更快速、更安全的肺静脉隔离:POWER-FAST III试验

2025-02-012
PRE
The European Society of Cardiology quality indicators in atrial fibrillation in centers of excellence in Spain: the SEC-EXCELENTE FA registry

欧洲心脏病学会在西班牙卓越中心的心房颤动质量指标:SEC-EXCELENTE FA登记研究

2024-09-011
PRE
Safety of pulsed field ablation in more than 17,000 patients with atrial fibrillation in the MANIFEST-17K study

17,000例以上心房颤动患者脉冲场消融安全性的MANIFEST-17K研究

2024-07-0822
OA
Response rate in cardiac resynchronization therapy patients implanted with a left ventricular quadripolar lead and the MultiPoint™ pacing feature early activated. QUARTO III
2022-12-290
PRE